Because of the problems which currently exist with the use of standard triple therapy, particularly resistance to methronidazolee and Clarithromycine, the world wide community of gastroenterologists faces a new challenge in the eradication of H. pylori: finding other treatment schemes to use which are well tolerated, economical, and highly effective.
Por los inconvenientes actualmente existentes con la TTE, la comunidad gastroenterológica mundial, tiene el reto de erradicar H. pylori utilizando esquemas que sean bien tolerados, económicos y altamente eficaces cuando exista resistencia a metronidazol y claritromicina.